Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

[Rethinking of preoperative induction chemotherapy in advanced esophageal cancer guiding by 7th TNM staging system].

Guo XF, Fang WT.

Zhonghua Wai Ke Za Zhi. 2013 Jan 1;51(1):14-7. Chinese. No abstract available.

PMID:
23578420
2.

Prognostic impact of the 6th and 7th American Joint Committee on Cancer TNM staging systems on esophageal cancer patients treated with chemoradiotherapy.

Nomura M, Shitara K, Kodaira T, Hatooka S, Mizota A, Kondoh C, Yokota T, Takahari D, Ura T, Muro K.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):946-52. doi: 10.1016/j.ijrobp.2010.12.045. Epub 2011 Feb 28.

PMID:
21362578
3.

Three-arm phase III trial comparing cisplatin plus 5-FU (CF) versus docetaxel, cisplatin plus 5-FU (DCF) versus radiotherapy with CF (CF-RT) as preoperative therapy for locally advanced esophageal cancer (JCOG1109, NExT study).

Nakamura K, Kato K, Igaki H, Ito Y, Mizusawa J, Ando N, Udagawa H, Tsubosa Y, Daiko H, Hironaka S, Fukuda H, Kitagawa Y; Japan Esophageal Oncology Group/Japan Clinical Oncology Group.

Jpn J Clin Oncol. 2013 Jul;43(7):752-5. doi: 10.1093/jjco/hyt061. Epub 2013 Apr 26.

PMID:
23625063
4.

Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.

Hsu PK, Wu YC, Chou TY, Huang CS, Hsu WH.

Ann Thorac Surg. 2010 Apr;89(4):1024-31. doi: 10.1016/j.athoracsur.2010.01.017.

PMID:
20338302
5.

[Histological effect and prognosis after preoperative chemotherapy in esophageal cancer].

Ohara M, Ishihara K, Abe T, Yamazaki S, Miura T, Tanabe Y, Kusano M, Okayasu T, Hosokawa M, Fujita M.

Rinsho Byori. 1995 Mar;43(3):238-46. Japanese.

PMID:
7745829
6.

[Preliminary experience of clinical applications of the 7th UICC-AJCC TNM staging system of esophageal carcinoma].

Lü F, Xue Q, Shao K, Mao YS, Gao SG, Mu JW, Tan FW, Cheng GY, He J.

Zhonghua Zhong Liu Za Zhi. 2012 Jun;34(6):461-4. doi: 10. 3760/cma.j.issn.0253-3766.2012.06.013. Chinese.

PMID:
22967450
7.

[Current status of neoadjuvant chemotherapy for advanced esophageal cancer].

Tanabe S, Shirakawa Y, Maeda N, Katsube R, Ohara T, Sakurama K, Noma K, Fujiwara T.

Gan To Kagaku Ryoho. 2013 Nov;40(12):1612-4. Japanese.

PMID:
24393865
8.

The role of multimodality therapy for esophageal cancer.

Krasna MJ, Tepper J.

Chest Surg Clin N Am. 2000 Aug;10(3):591-603. Review.

PMID:
10967760
9.

[A case of advanced esophageal cancer with no recurrence treated biweekly with postoperative docetaxel/nedaplatin combined chemotherapy after non-curative surgery].

Sugimoto K, Sasaki K, Karaki H, Okaya T, Suzuki H, Hayashi S, Yamamoto K, Yamamori H, Sugano I.

Gan To Kagaku Ryoho. 2010 Jun;37(6):1101-3. Japanese.

PMID:
20567116
10.

[Preoperative chemotherapy and advances in surgery].

Peracchia A, Bardini R, Toso S, de Besi P.

Pathol Biol (Paris). 1989 Feb;37(2):142-3. French. No abstract available.

PMID:
2469055
11.

Impact of neoadjuvant chemoradiation in early esophageal cancers.

Mariette C, Robb WB.

Ann Thorac Surg. 2012 Oct;94(4):1374-5. doi: 10.1016/j.athoracsur.2012.03.091. No abstract available.

PMID:
23006706
12.

[A case report of esophageal carcinoma with grade 3 response by preoperative chemotherapy using CDDP/5-FU/LV].

Bando K, Onda M, Miyashita M, Takahashi Y, Takita M, Matsutani T, Okawa K, Sasajima K, Ujihara Y, Takubo K, Yamashita K.

Gan To Kagaku Ryoho. 1998 May;25(6):915-8. Japanese.

PMID:
9617331
13.

[Understanding and appraisal of the new TNM classification for esophageal cancer in the AJCC Cancer Staging Manual (7th edition)].

Chen LQ.

Zhonghua Zhong Liu Za Zhi. 2010 Mar;32(3):237-40. Chinese. No abstract available.

PMID:
20450597
14.

Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.

Kim HI, Cheong JH, Song KJ, An JY, Hyung WJ, Noh SH, Kim CB.

Ann Surg Oncol. 2013 Aug;20(8):2713-20. doi: 10.1245/s10434-013-2898-5. Epub 2013 Mar 2.

PMID:
23456315
15.

Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs.

Miyata H, Yamasaki M, Kurokawa Y, Takiguchi S, Nakajima K, Fujiwara Y, Mori M, Doki Y.

J Surg Oncol. 2012 Sep 15;106(4):441-7. doi: 10.1002/jso.23081. Epub 2012 Feb 27.

PMID:
22371189
16.

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Talsma K, van Hagen P, Grotenhuis BA, Steyerberg EW, Tilanus HW, van Lanschot JJ, Wijnhoven BP.

Ann Surg Oncol. 2012 Jul;19(7):2142-8. doi: 10.1245/s10434-012-2218-5. Epub 2012 Mar 7.

17.

[A case of esophageal cancer with intramural metastasis demonstrates a good clinical course after induction chemotherapy followed by chemoradiation].

Yoshii T, Ohkawa S, Watanabe T, Ogata T, Kitamura T.

Gan To Kagaku Ryoho. 2011 Nov;38(11):1845-8. Japanese.

PMID:
22083194
18.

[Efficacy of combined chemotherapy with nedaplatin, adriamycin, and 5-FU (NAF), and clinical factors affecting its effect in patients with advanced esophageal cancer].

Hasegawa H, Fujitani K, Hirao M, Nakazuru S, Mita E, Tsujinaka T.

Gan To Kagaku Ryoho. 2011 Dec;38(13):2591-5. Japanese.

PMID:
22189224
19.

[Pathological complete response in a case of advanced esophageal cancer invading aorta treated by preoperative chemotherapy with docetaxel and cisplatin plus 5-FU].

Nishino T, Yamamoto Y, Ikeda M, Morimoto M, Furukawa T, Goto M, Furukita Y, Takechi H, Seike J, Tangoku A, Fujiwara H.

Gan To Kagaku Ryoho. 2013 May;40(5):643-6. Japanese.

PMID:
23863591
20.

A preliminary study on the consistency between the non-surgical staging and the surgical-pathological staging in oesophageal carcinoma.

Luo HC, Lin GS, Cheng HH, Fu ZC.

Interact Cardiovasc Thorac Surg. 2012 Sep;15(3):344-7. doi: 10.1093/icvts/ivs187. Epub 2012 Jun 7.

Supplemental Content

Support Center